Clinical Trial Update: A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating MDMA-assisted Cognitive Processing Therapy (CPT) for post-traumatic stress disorder has completed. The trial is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Remedy | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: COMPLETED